Stay updated on Pembrolizumab with Radiotherapy in CTCL Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Radiotherapy in CTCL Clinical Trial page.

Latest updates to the Pembrolizumab with Radiotherapy in CTCL Clinical Trial page
- Check4 days agoChange DetectedBoth screenshots show only minor UI/formatting adjustments; there are no changes to the study design, eligibility criteria, primary/secondary outcomes, or participating locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check11 days agoNo Change Detected
- Check32 days agoChange DetectedCore content updated with an operating-status notice and a new topic/term added; the version is updated from v3.1.0 to v3.2.0, indicating a new release. There are no conflicting deletions that negate these additions.SummaryDifference3%

- Check40 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page revision has been updated from v3.0.1 to v3.0.2. The 'Back to Top' element has been removed.SummaryDifference0.2%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check68 days agoChange DetectedThe web page has added significant medical content related to radiation therapy and specific diseases, while removing several related terms and conditions, indicating a shift in focus or an update in the information provided.SummaryDifference6%

Stay in the know with updates to Pembrolizumab with Radiotherapy in CTCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radiotherapy in CTCL Clinical Trial page.